AIToday
AI in HealthcareHacker NewsPublished: Aug 11, 2026, 01:01 JST4 min read

AI tool shrinks proteins by 10–15% while preserving function

AI tool shrinks proteins by 10–15% while preserving function

Key takeaway

  • Duke University researchers have created an AI program called Raygun that shrinks proteins by 10–15% while preserving their function, a breakthrough published in Nature.

  • The tool identifies which amino acids are critical by analyzing evolutionary patterns, making it potentially useful for medical applications like gene therapy and biological imaging, where smaller proteins would fit more easily into delivery vehicles or interfere less with tagging.

3 Key Points

  1. What happened

    Researchers at Duke University have developed an AI program called Raygun that can suggest cuts to a protein's amino acid sequence, reducing overall size without losing function. The tool shrank fluorescent proteins EGFP and mCherry by 10–15%, and the resulting proteins still glowed under excitation.

  2. Why it matters

    Smaller proteins could reduce interference when tagging biological processes, and shrinking sequences may help gene therapy by fitting into the limited capacity of delivery vehicles like adeno-associated viruses. The approach works by learning from evolutionary patterns in protein sequences to identify critical pieces, rather than testing mutations one at a time.

  3. What to watch

    The tool can also expand proteins, which researchers are still developing—a capability that could help add new domains to existing proteins. Raygun is not positioned as a replacement for de novo protein design (creating proteins from scratch) but rather as a complement; both techniques could be used together.

In Depth

Read the full story

Duke University researchers, led by computational biologist Rohit Singh in collaboration with colleague Scott Soderling, have developed an AI-based program called Raygun that can strategically reduce a protein's size without compromising its function. The tool works by analyzing evolutionary patterns embedded in protein sequences to identify which amino acids are truly critical. As Singh explains, "This is an approach that essentially reasons from evolutionary patterns in protein sequences to figure out what the critical pieces are. You can ask for much more extensive substitutions than you would typically have by point-by-point mutations."

In initial tests, Raygun shrank two widely used fluorescent proteins—EGFP and mCherry—by 10–15% while preserving their luminescent properties; the resulting proteins still glowed when exposed to excitation. The findings were published in Nature (2026, DOI: 10.1038/s41586-026-10842-8).

The applications are significant for two major areas of biomedicine. In imaging, miniaturized fluorescent protein tags could reduce their intrusiveness when marking biological processes and tissues, lowering the risk that the tag itself distorts the system being observed. In gene therapy, one of the core challenges is the limited cargo capacity of delivery vehicles like adeno-associated viruses; shrinking therapeutic proteins could open up new treatment possibilities. Singh notes that the two leading strategies in protein engineering—de novo design (creating proteins from scratch) and Raygun's approach (optimizing existing sequences)—are not competitors. Instead, they complement each other: "De novo design is about creating something in an entirely new part of the protein space. Raygun is about exploring the space around it more effectively. So you could actually make a de novo design and then still apply Raygun on top of it to then explore the space around that specific novel design."

Looking forward, the team is developing an additional capability: the ability to expand proteins as well as shrink them. While counterintuitive, expanding a protein could be valuable if researchers want to integrate a new functional domain into an existing protein scaffold. This bidirectional flexibility suggests Raygun may become a versatile tool for protein optimization across a range of biotechnology applications.

Context & Analysis

Raygun represents a distinct strategy in protein engineering: rather than designing proteins entirely from scratch, it works within the boundaries of known protein sequences, using AI to identify which amino acids are truly essential and which can be removed or substituted. This approach, led by computational biologist Rohit Singh at Duke University, harnesses evolutionary patterns embedded in protein sequences to guide the search for critical components—a method that allows for more extensive modifications than traditional point-by-point mutation testing would suggest.

The practical implications align with real bottlenecks in biotechnology. Gene therapy faces a fundamental constraint: viral delivery vehicles have limited carrying capacity, and any reduction in the size of a therapeutic protein could expand the range of candidates. Similarly, fluorescent protein tags, while invaluable for imaging biological processes, can sometimes alter the very systems they are meant to observe; miniaturizing them could mitigate this interference. Singh's team views Raygun not as a replacement for de novo design but as a complementary tool that can operate on top of newly engineered proteins, effectively allowing researchers to refine and optimize novel designs further.

FAQ

How much did Raygun shrink the test proteins?
The tool shrank fluorescent proteins EGFP and mCherry by 10–15%, and the resulting proteins still glowed under excitation.
How is Raygun different from designing proteins from scratch?
De novo design creates entirely new proteins; Raygun explores the space around an existing protein more effectively by learning from evolutionary patterns. The two approaches could even be used together—applying Raygun to a newly designed protein to explore variants of it.

Get the latest AI in Healthcare news every morning

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytime

Ask AI

Ask AI anything about this article. Q&As are published on this page for other readers too.

Related Articles

Next articleZuckerberg's 6,500-word AI essay: open models, data centers, less regulation

The AI news that matters, in one minute each morning.

Sign up free